Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) shares were up 2.7% during mid-day trading on Thursday . The company traded as high as $7.46 and last traded at $7.34. Approximately 222,880 shares changed hands during mid-day trading, a decline of 60% from the average daily volume of 551,962 shares. The stock had previously closed at $7.15.
Cybin Stock Up 3.7 %
The company’s 50-day moving average is $9.03 and its 200-day moving average is $8.47. The stock has a market capitalization of $1.12 billion and a price-to-earnings ratio of -31.54.
About Cybin
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Further Reading
- Five stocks we like better than Cybin
- 3 Healthcare Dividend Stocks to Buy
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What Are the U.K. Market Holidays? How to Invest and Trade
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What is the Hang Seng index?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
